Characteristics | SLE patients (n = 51) | Controls (n = 49) | P Value |
---|---|---|---|
PON1 paraoxonase activity (U/l) | 118.01 ± 85.49 | 124.68 ± 102.96 | 0.857 |
PON1 arylesterase activity (U/l) | 125.65 ± 26.87 | 148.35 ± 39.34 | 0.001 |
Paraoxonase activity/HDL | 98.48 ± 69.92 | 76.20 ± 64.34 | 0.025 |
Arylesterase activity/HDL | 109.05 ± 38.23 | 93.51 ± 33.30 | 0.036 |
Total HDL antioxidant capacity (%) | 165.82 ± 58.28 | 217.71 ± 54.36 | <0.001 |
OxLDL (mg/l) | 3.55 ± 4.19 | 2.63 ± 3.22 | 0.291 |
HsCRP (mg/l) | 5.02 ± 6.64 | 1.68 ± 1.88 | 0.002 |
ESR (mm/hour) | 24.38 ± 17.96 | 7.90 ± 5.93 | <0.001 |
IL-6 (ng/l) | 0.54 (0–3.25) | 0 (0–0.17) | 0.002 |
SAA (ug/l) | 19017.07 ± 25899.25 | 2666.05 ± 2301.11 | <0.001 |
MCP-1 (ng/l) | 473.24 (342.72-599.16) | 309.72 (242.91-353.86) | <0.001 |
SAA/HDL (ug/mmol) | 18217.14 ± 29453.17 | 1692.24 ± 1459.34 | <0.001 |